Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117045) titled 'Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer' on Aug. 5.
Study Type: Observational
Primary Sponsor: Changhai Hospital
Condition:
Pancreatic Cancer
Intraductal Papillary Mucinous Neoplasm
High-grade Pancreatic Intraepithelial Neoplasia
PDAC - Pancreatic Ductal Adenocarcinoma
Mucinous Cystic Neoplasm
Intervention:
Diagnostic Test: Diagnostic Evaluation for Positive AI Findings
Recruitment Status: Recruiting
Date of First Enrollment: August 15, 2025
Target Sample Size: 400000
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/...